Tradition and change intertwine to create beauty at a century-old arboretum
OYSTER BAY, N.Y. (AP) — Some places seem to communicate with you when you visit. Not audibly, of course, but they somehow impart the echo of a life lived long ago. That's the feeling I get at Planting Fields Arboretum State Historic Park.
The 409-acre remnant of Long Island's grand Gold Coast is one of the region's last surviving estates with its original acreage intact, which is remarkable when you consider how many of its cohorts have been divided up into housing developments or golf courses.
But it isn't frozen in time. Recently, the site has been undergoing a multi-million dollar revitalization with a focus on biodiversity and native plantings rather than adherence to the plant palette selected for the property more than a century ago.
It's a shift in emphasis that's gaining traction in many historic gardens.
The new focus on sustainability was also evident when the arboretum recently replaced its storied half-mile-long double allée of European beech trees with native oaks. And meadows throughout the property, which have historically been mowed regularly, are now cut back just once or twice a year to allow a natural habitat to thrive.
A new book looks at a layered history
A new book, 'Planting Fields: A Place on Long Island,' offers fresh perspective into the now-public arboretum. Full of color photography, both vintage and current (by David Almeida); sketches and plans by the famed Olmsted Brothers, who designed the landscape; and essays by architect Witold Rybczynski, landscape historian John Dixon Hunt and others, it's an homage to the home and property.
At Planting Fields, the rolling lawns, gardens and woodland paths still command attention, anchored by Coe Hall, a sprawling Tudor Revival mansion.
The estate started taking shape in 1913, when English immigrant William Robertson Coe, chairman of the marine insurance company Johnson and Higgins, and his wife, Mai Rogers Coe, an heiress to the Standard Oil fortune, bought the land, which had once been a working farm. The couple used it as a country retreat.
Coe Hall was something of a 20th-century fantasy, deliberately built to look centuries old.
'The Coes were new money, but they didn't want it to look like new money,' said Gina J. Wouters, president and CEO of Planting Fields Foundation and co-editor of the book, with Jerome E. Singerman. 'They wanted it to look like they had generations of wealth.'
So, they brought in the best craftspeople of their time. There's ironwork by Samuel Yellin, murals by Everett Shinn and Robert Winthrop Chanler and interiors by Elsie de Wolfe, who imparted a whimsical flair to the home.
The landscape, originally drafted by Boston landscape architect Andrew Sargent and his partner Guy Lowell, became a full-fledged Olmsted Brothers vision after Sargent died in 1918. There's a formal Italian Garden, circular pool garden and greenhouses, including one that holds the largest camellia collection in the Northeast.
'Without a doubt, our claim to fame is that Planting Fields is the largest, still-existing Olmsted Brothers residential commission,' Wouters said. 'Other properties have been sold off, turned into wedding venues, etc., but Planting Fields is the original 409 acres. Even on a national scale, that's extraordinary.'
A continued emphasis on craftsmanship
The Coes themselves were hands-on, taking interest in breeding animals, collecting and hybridizing plants, patronizing contemporary artists and interior decorating.
In keeping with the couple's penchant for hiring first-rate contemporary experts, Planting Fields has recently invited renowned Dutch garden and landscape designer Piet Oudolf to create a 1-acre garden for the property. The plan, Wouters said, is to use Oudolf's four-season approach and include perennial gardens and year-round beauty in keeping with the historic design of the property.
Wouters hopes the book imparts "an understanding of the incredibly layered history of Planting Fields and the stewardship model that is guiding us today and ushering us into the future.'
She hopes readers will also feel compelled to visit.
'W.R. Coe gifted the property to the people of the state of New York – not the state of New York – the people," she said. "That's important.'
___
Jessica Damiano writes weekly gardening columns for the AP and publishes the award-winning Weekly Dirt Newsletter. You can sign up here for weekly gardening tips and advice.
___
For more AP gardening stories, go to https://apnews.com/hub/gardening.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
37 minutes ago
- Yahoo
Ukraine plots fracking revolution
Ukraine is working to unleash natural gas fracking with the goal of becoming a major exporter and revolutionising Europe's energy market. In plans critical to Volodymyr Zelensky's hopes of a post-war economic recovery, ministers in Kyiv are scrambling to lure private investment and gain access to new drilling technology to access the country's vast untapped shale gas resources. According to sources close to Kyiv, officials are racing to attract 'foreign technology and highly experienced subsoil users', with a focus on unconventional shale resources in western Ukraine. The hunt for cash - as revealed by the independent news platform Energy Flux - is being conducted in parallel to the rare earth minerals deal struck between Donald Trump and President Zelensky in April, which will allow the US to exploit Ukraine's natural resources, including aluminium, graphite, oil and natural gas. The priority is to rapidly revitalise Ukraine's ailing gas sector after a gruelling winter saw roughly 40pc of production capacity taken out by a fierce Russian campaign of drone and missile strikes. The attacks forced Ukraine to draw heavily on its gas stocks, which ended winter almost entirely depleted. But Ukraine's Ministry of Energy believes it is possible to refill the country's cavernous underground storage facilities and even produce a surplus for export 'within 18 months', according to a senior government source. Ukraine already has some experience with advanced drilling technology for old wells and has since carried out experimental trials that 'confirm its potential' for fracking, they said. However, to unlock Ukraine's shale reserves, the country needs to attract more investment and newer kit, primarily from America. 'Development and production can be quickly developed using available gas infrastructure with connections to the EU gas market that make it very attractive,' the source added. 'Ukraine has enough deposits of traditional gas to cover its own consumption and to become a net exporter, and shale gas production has quite a profound effect on its development.' Such a turnaround would help transform the fortunes of Europe's energy markets, which remain on edge following the loss of Russian pipeline gas exports via Ukraine at the start of 2025. Refilling Ukraine's depleted gas storage – the largest in Europe, at 32bn cubic metres – is one of the main factors tightening energy markets in Central and Eastern Europe ahead of next winter. Ukraine's gas stocks are today just 7pc full compared to the EU average of 50pc. Efforts to pipe natural gas from Southern and Eastern Europe into Ukraine have also been thwarted by red tape and a lack of market cohesion. However, if Ukraine could unleash its own shale revolution and create a surplus for export, the need to keep pumping European gas into Ukraine would effectively disappear overnight. It would also help reduce Europe's reliance on costly liquefied natural gas (LNG) supplies from overseas. Gas-starved Europe leaned heavily on LNG after Gazprom, the Kremlin-backed energy giant, halted exports to the EU following Vladimir Putin's full-scale invasion of Ukraine in 2022. Ukrainian shale gas exports, if scaled up quickly, would erase a large chunk of European energy demand currently being met by LNG, potentially sparking a sharp drop in energy prices around the world. However, Kyiv's proposed fracking revolution hinges largely on the country's ability to secure overseas investment. Officials from Ukraine's Ministry of Energy are tapping Western diplomatic ties to find private capital funds with a high tolerance for risk to bankroll drilling and bring in technology partners. A senior government team attended the Baku Energy Forum in Azerbaijan last week in part to promote Ukraine's potential as a shale hub. Speaking at the event, one high-ranking statesman said the Lviv-Lublin geological area that straddles the Ukraine-Poland border is 'superior on the Ukrainian side' thanks to higher porosity and lower clay content, making it 'better for fracking'. The most promising prospect is the Oleska (Olesskaya) shale block, which contains an estimated 0.8 to 1.5 trillion cubic metres of shale gas resources – enough to meet Ukraine's domestic needs for decades. How much of this resource is economically recoverable is an open question. Chevron walked away from a 50pc interest in the Oleska project in 2014 before drilling could begin. Chevron's stated reason for leaving was not because of political instability or lack of resources, but rather Kyiv's failure to enact specific tax reforms necessary to enable shale gas foreign investment. Now, the Zelensky administration is moving to streamline operations and reduce bureaucratic hurdles that previously deterred foreign investors. Ownership of the Olesskaya production sharing agreement (PSA) was transferred in April 2025 from government holding company Nadra Ukraine to Ukraine's largest oil and gas producer, Ukrnafta. The move signalled a strategic shift in the country's approach to fracking, particularly in the Oleska block. Ukrnafta is a state-owned enterprise following the nationalisation of strategic industries and declaration of martial law in 2022, which remains in force to this day. Attracting significant private capital into Ukrainian shale exploration would normally be impossible under these circumstances. However, the source said there are laws in place to ensure they can be overwritten. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Yahoo
an hour ago
- Yahoo
European Market Insights: genOway Société anonyme And 2 Promising Penny Stocks
The European market has shown resilience with the pan-European STOXX Europe 600 Index rising by 0.90%, buoyed by a slowdown in inflation and easing monetary policy from the European Central Bank. As investors navigate these evolving conditions, penny stocks—often representing smaller or newer companies—continue to capture interest for their potential growth at accessible price points. Despite being an outdated term, penny stocks remain relevant as they can offer opportunities for those seeking to invest in financially strong companies with promising prospects. Name Share Price Market Cap Financial Health Rating Mistral Iberia Real Estate SOCIMI (BME:YMIB) €1.01 €22M ★★★★★☆ KebNi (OM:KEBNI B) SEK1.996 SEK541.22M ★★★★★★ Angler Gaming (NGM:ANGL) SEK3.61 SEK270.7M ★★★★★★ Cellularline (BIT:CELL) €2.95 €62.22M ★★★★★☆ Fondia Oyj (HLSE:FONDIA) €4.78 €17.87M ★★★★★★ Abak (WSE:ABK) PLN4.00 PLN10.78M ★★★★★★ Bredband2 i Skandinavien (OM:BRE2) SEK2.38 SEK2.28B ★★★★☆☆ Hifab Group (OM:HIFA B) SEK3.62 SEK220.24M ★★★★★★ Deceuninck (ENXTBR:DECB) €2.175 €300.29M ★★★★★★ Netgem (ENXTPA:ALNTG) €0.936 €31.34M ★★★★★★ Click here to see the full list of 447 stocks from our European Penny Stocks screener. Let's dive into some prime choices out of the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: genOway Société anonyme is a biotechnology company that develops and commercializes custom genetically modified mouse, rat, and cell line models globally, with a market cap of €31.44 million. Operations: The company's revenue is derived entirely from its biotechnology segment, amounting to €27.53 million. Market Cap: €31.44M genOway Société anonyme, with a market cap of €31.44 million, has shown consistent revenue growth, reporting €22.06 million in sales for 2024, up from €20.05 million the previous year. The company maintains strong financial health with short-term assets exceeding both its short and long-term liabilities and a satisfactory net debt to equity ratio of 3.4%. Despite not outperforming the biotech industry in earnings growth last year, genOway's profitability has improved over five years at an impressive annual rate of 67.1%, supported by high-quality earnings and stable weekly volatility at 6%. Click here and access our complete financial health analysis report to understand the dynamics of genOway Société anonyme. Learn about genOway Société anonyme's historical performance here. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Kudelski SA, with a market cap of CHF67.34 million, offers digital access and security solutions for digital television and interactive applications across Switzerland, the United States, France, Germany, Austria, and other international markets. Operations: The company's revenue is primarily derived from three segments: Digital TV ($227.83 million), Cybersecurity ($108.47 million), and Internet of Things ($47.43 million). Market Cap: CHF67.34M Kudelski SA, with a market cap of CHF67.34 million, operates in digital access and security solutions across multiple markets. Despite being unprofitable with increasing losses over the past five years, it holds strong financials with short-term assets exceeding liabilities and more cash than debt. The seasoned management team and board bring stability, while recent partnerships in IoT and AI sectors highlight strategic growth efforts. Notably, Kudelski's collaboration with Stotz Equipment enhances asset visibility solutions without subscription fees, potentially driving future revenue streams within diverse industries like agriculture and construction. The stock trades significantly below estimated fair value compared to peers. Navigate through the intricacies of Kudelski with our comprehensive balance sheet health report here. Evaluate Kudelski's prospects by accessing our earnings growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: PCC Exol S.A. manufactures and distributes surfactants both in Poland and internationally, with a market cap of PLN452.76 million. Operations: The company's revenue is primarily derived from its Specialty Chemicals segment, totaling PLN996.33 million. Market Cap: PLN452.76M PCC Exol S.A., with a market cap of PLN452.76 million, shows promising financials as its short-term assets exceed both long-term and short-term liabilities. The company's earnings growth of 23.1% over the past year surpasses its five-year average and outpaces the broader Chemicals industry growth rate. However, while interest payments are well covered by EBIT, operating cash flow covers only 17% of debt, indicating potential liquidity concerns. Despite a high net debt to equity ratio of 54.1%, PCC Exol maintains high-quality earnings with no significant shareholder dilution recently and offers a price-to-earnings ratio below the Polish market average. Get an in-depth perspective on PCC Exol's performance by reading our balance sheet health report here. Explore historical data to track PCC Exol's performance over time in our past results report. Take a closer look at our European Penny Stocks list of 447 companies by clicking here. Interested In Other Possibilities? These 18 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTPA:ALGEN SWX:KUD and WSE:PCX. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
an hour ago
- Yahoo
High Growth Tech Stocks To Watch In Europe June 2025
As the European markets experience a boost, with the STOXX Europe 600 Index climbing by 0.90% amid easing inflation and supportive monetary policy from the European Central Bank, investors are increasingly focusing on high-growth sectors such as technology. In this environment, identifying promising tech stocks involves looking for companies that can leverage favorable economic conditions and technological advancements to drive substantial growth. Name Revenue Growth Earnings Growth Growth Rating Intellego Technologies 30.80% 45.66% ★★★★★★ Archos 21.07% 36.58% ★★★★★★ KebNi 21.51% 66.96% ★★★★★★ Pharma Mar 29.61% 44.92% ★★★★★★ Bonesupport Holding 29.14% 56.14% ★★★★★★ argenx 21.50% 26.61% ★★★★★★ Skolon 31.51% 99.52% ★★★★★★ Xbrane Biopharma 24.95% 56.77% ★★★★★★ Diamyd Medical 86.29% 93.04% ★★★★★★ Elliptic Laboratories 36.33% 78.99% ★★★★★★ Click here to see the full list of 226 stocks from our European High Growth Tech and AI Stocks screener. Let's explore several standout options from the results in the screener. Simply Wall St Growth Rating: ★★★★★★ Overview: argenx SE is a commercial-stage biopharma company focused on developing therapies for autoimmune diseases across several countries including the United States, Japan, China, and the Netherlands, with a market cap of €31.52 billion. Operations: argenx focuses on developing therapies for autoimmune diseases, generating revenue primarily from its biotechnology segment, which reported $2.64 billion. The company's operations span multiple countries, including the United States, Japan, China, and the Netherlands. argenx SE has demonstrated remarkable growth with a surge in revenue to $807.37 million, doubling from the previous year's $412.51 million, alongside transitioning from a net loss to a substantial net income of $169.47 million. This financial turnaround is underscored by robust R&D commitments, crucial for sustaining innovation and competitiveness in the biotech landscape. The firm's recent CHMP nod for VYVGART® in CIDP treatment further highlights its strategic focus on expanding therapeutic applications, promising continued relevance and impact within the healthcare sector. Click here to discover the nuances of argenx with our detailed analytical health report. Understand argenx's track record by examining our Past report. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Believe S.A. is a company that offers digital music services to independent labels and local artists across various regions including France, Germany, the rest of Europe, the Americas, Asia, Oceania, and the Pacific with a market cap of approximately €1.72 billion. Operations: The company's revenue primarily comes from Premium Solutions, generating €924.24 million, while Automated Solutions contribute €64.59 million. Believe, a European tech entity, is navigating its path towards profitability with expected earnings growth of 96.9% annually. Despite current unprofitability, its revenue growth outpaces the French market's average at 13.4% per year compared to 5%. This growth trajectory is supported by strategic moves such as the proposed acquisition by TCMI Inc., EQT X, and Denis Ladegaillerie for a €57.9 million stake, enhancing financial stability and market presence. Moreover, Believe's commitment to R&D aligns with industry demands for continuous innovation, ensuring it remains competitive in the dynamic tech landscape. Get an in-depth perspective on Believe's performance by reading our health report here. Examine Believe's past performance report to understand how it has performed in the past. Simply Wall St Growth Rating: ★★★★★☆ Overview: Comet Holding AG, along with its subsidiaries, delivers X-ray and radio frequency (RF) power technology solutions globally across Europe, North America, and Asia, with a market capitalization of CHF1.79 billion. Operations: The company generates revenue through three main segments: X-Ray Systems (CHF115.89 million), Industrial X-Ray Modules (CHF94.57 million), and Plasma Control Technologies (CHF247.39 million). Comet Holding AG, a Swiss tech firm, is making notable strides with an earnings growth of 37.3% annually, significantly outpacing the local market's average of 10.7%. This robust performance is further underscored by its revenue increase of 12.2% per year, which also surpasses the Swiss market growth rate of 4.2%. Notably, Comet's commitment to innovation is evident in its R&D spending, crucial for maintaining technological leadership in a competitive sector. Recent corporate actions include electing Benjamin Loh as Chairman and approving a dividend increase to CHF 1.50 per share, signaling strong governance and shareholder confidence amidst a promising financial trajectory marked by first-quarter sales surging by 37.5% year-over-year to CHF 111.2 million. Take a closer look at Comet Holding's potential here in our health report. Assess Comet Holding's past performance with our detailed historical performance reports. Dive into all 226 of the European High Growth Tech and AI Stocks we have identified here. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTBR:ARGX ENXTPA:BLV and SWX:COTN. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@